Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 20, 2010

View Archived Issues

Cancer vaccine CDX-1401 safe and active in ongoing phase I/II trial

Snapshots: Studies of new antibiotic CB-182804

Neurocrine Biosciences advances NBI-98854 into phase II testing

Aastrom obtains FDA fast track status for phase III CLI program

HIV vaccine ALVAC vCP1521 is safe in infants given birth to by HIV-infected women

DepoVax-based vaccination leads to tumor regression in vivo

Helix BioPharma files IND for phase II/III trial of IFN-alpha-2b for low-grade cervical lesions

Baraclude approved as therapy for chronic hepatitis B in adults with decompensated liver disease

Bharat Biotech launches H1N1 flu vaccine HNVAC in India

European orphan drug status for recombinant porcine factor VIII in hemophilia A

DiaMedica reports final data from DM-99 study in type 1 diabetes

Prolong Pharma secures funds to support programs in anemia

EMA recommends approval of CTI's pediatric investigation plan for Pixuvri

Sepracor changes name to Sunovion Pharmaceuticals

Two doses of Duromist oral spray show bioequivalence to Viagra tablet

New phosphodiesterase 7/8 inhibitors identified at sanofi-aventis

NeurogesX to submit sNDA to FDA for Qutenza patch in HIV-associated neuropathy

FDA grants fast track status for HPN-100 in urea cycle disorders

Vertex initiates phase IIa trial of VX-770/VX-809 for cystic fibrosis

Pathway Therapeutics presents new inhibitors of PI3K isoforms

Abbott describes novel GSK-3 beta inhibitors

Merck & Co. claims new diacylglycerol O-acyltransferase 1 inhibitors

New selective alpha2C-adrenoceptor agonists identified

Ocrelizumab reduces disease activity in phase II trial in relapsing-remitting MS

EC grants orphan drug status for S*BIO's SB-1518 in myelofibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...